Atea Pharmaceuticals, Inc. (AVIR) Operating Lease, Liability USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Atea Pharmaceuticals, Inc. quarterly Operating Lease, Liability history and growth rate from 2021 to 2024.
  • Atea Pharmaceuticals, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $2.21 M, a 24.8% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $2.21 M -$731 K -24.8% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.4 M -$722 K -23.1% Dec 31, 2023 10-K 2024-02-28
Q3 2023 $2.59 M -$711 K -21.6% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $2.77 M -$730 K -20.9% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.95 M +$69 K +2.4% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $3.12 M Dec 31, 2022 10-K 2023-02-28
Q3 2022 $3.3 M +$3.02 M +1081% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $3.5 M +$3.14 M +868% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $2.88 M +$2.44 M +558% Mar 31, 2022 10-Q 2022-05-10
Q3 2021 $279 K Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $361 K Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $437 K Mar 31, 2021 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.